GMPriority Pharma News

As consumers continue to demand evidence, convenience and sustainability, 2026 will be a pivotal year where premium delivery technologies, particularly clinically validated, high-bioavailability formats, will separate meaningful innovation from social-media hype. The supplement market is evolving beyond empty promises, with established beauty and personal care brands entering the nutraceutical space, bringing rigor, measurement and credible […]

We’re honoured to announce that GMPriority Pharma has been awarded the Business Transformation Award at the Innovate UK Knowledge Transfer Partnership (KTP) Awards 2025, held on 28th October at the Kimpton Clocktower Hotel in Manchester. The annual KTP Awards celebrate the exceptional achievements of graduates, universities, and businesses that drive innovation and collaboration across the […]

Clarifying the Role of Liposomal Technology and the Need for Evidence-Based Communication in Supplement Manufacturing Published by GMPriority PharmaDate: July 2025 Abstract Recent consumer-facing communications have attributed visible crystallisation in liquid magnesium supplements to the natural byproduct of liposomal encapsulation, further implying that the absence of chemical stabilisers reflects a more desirable, “natural” formulation. These […]